1. Home
  2. EVGN vs CHRO Comparison

EVGN vs CHRO Comparison

Compare EVGN & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVGN
  • CHRO
  • Stock Information
  • Founded
  • EVGN 1999
  • CHRO 2002
  • Country
  • EVGN Israel
  • CHRO United States
  • Employees
  • EVGN N/A
  • CHRO N/A
  • Industry
  • EVGN Agricultural Chemicals
  • CHRO
  • Sector
  • EVGN Industrials
  • CHRO
  • Exchange
  • EVGN Nasdaq
  • CHRO Nasdaq
  • Market Cap
  • EVGN 9.7M
  • CHRO 8.1M
  • IPO Year
  • EVGN N/A
  • CHRO 2024
  • Fundamental
  • Price
  • EVGN $1.11
  • CHRO $1.37
  • Analyst Decision
  • EVGN Strong Buy
  • CHRO Strong Buy
  • Analyst Count
  • EVGN 1
  • CHRO 1
  • Target Price
  • EVGN $12.00
  • CHRO N/A
  • AVG Volume (30 Days)
  • EVGN 1.1M
  • CHRO 2.1M
  • Earning Date
  • EVGN 05-22-2025
  • CHRO 05-14-2025
  • Dividend Yield
  • EVGN N/A
  • CHRO N/A
  • EPS Growth
  • EVGN N/A
  • CHRO N/A
  • EPS
  • EVGN N/A
  • CHRO N/A
  • Revenue
  • EVGN $8,511,000.00
  • CHRO N/A
  • Revenue This Year
  • EVGN $68.62
  • CHRO N/A
  • Revenue Next Year
  • EVGN $66.92
  • CHRO N/A
  • P/E Ratio
  • EVGN N/A
  • CHRO N/A
  • Revenue Growth
  • EVGN 50.90
  • CHRO N/A
  • 52 Week Low
  • EVGN $0.95
  • CHRO $0.45
  • 52 Week High
  • EVGN $9.00
  • CHRO $3.80
  • Technical
  • Relative Strength Index (RSI)
  • EVGN 44.93
  • CHRO 46.67
  • Support Level
  • EVGN $1.05
  • CHRO $1.29
  • Resistance Level
  • EVGN $1.34
  • CHRO $1.65
  • Average True Range (ATR)
  • EVGN 0.09
  • CHRO 0.20
  • MACD
  • EVGN 0.01
  • CHRO 0.02
  • Stochastic Oscillator
  • EVGN 41.03
  • CHRO 13.81

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

Share on Social Networks: